Most Common Side Effects: Just like other GLP-1 medications, gastrointestinal issues were the most common: Nausea (especially during dose increases) Diarrhea Vomiting Constipation Abdominal pain The frequency: Higher with 8 mg and 12 mg doses compared to lower doses
That enrolment breakdown is worth stating carefully, because the trials own abstract phrases it in a way that is easy to misread: it says 706 participants were assigned to cagrilintide 0.34.5 mg (100102 per dose group), 99 to liraglutide 3.0 mg, and 101 to placebo. Read literally, that would put the trial at over 900 people
, GLP-1, Wegovy (Novo Nordisk) Mounjaro (Eli Lilly),
A 4 mL vial at 20mg/mL contains 80mg total, which provides sixteen 5mg doses
Insulin Optimization: After meals, Ozempic 2.0 helps the pancreas release insulin more efficiently